Found: 36
Select item for more details and to access through your institution.
Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Guidance on the implementation and reporting of a drug safety Bayesian network meta-analysis.
- Published in:
- Pharmaceutical Statistics, 2014, v. 13, n. 1, p. 55, doi. 10.1002/pst.1592
- By:
- Publication type:
- Article
A Bayesian approach to the statistical analysis of device preference studies.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 2, p. 149, doi. 10.1002/pst.522
- By:
- Publication type:
- Article
Enabling Eating Detection in a Free-living Environment: Integrative Engineering and Machine Learning Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Power and commensurate priors for synthesizing aggregate and individual patient level data in network meta‐analysis.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 2018, v. 67, n. 4, p. 1047, doi. 10.1111/rssc.12275
- By:
- Publication type:
- Article
MULTICATEGORY OUTCOME WEIGHTED MARGIN-BASED LEARNING FOR ESTIMATING INDIVIDUALIZED TREATMENT RULES.
- Published in:
- Statistica Sinica, 2020, v. 30, n. 4, p. 1857, doi. 10.5705/ss.202017.0527
- By:
- Publication type:
- Article
Evaluating and utilizing probability of study success in clinical development.
- Published in:
- Clinical Trials, 2013, v. 10, n. 3, p. 407, doi. 10.1177/1740774513478229
- By:
- Publication type:
- Article
Risk controlled decision trees and random forests for precision Medicine.
- Published in:
- Statistics in Medicine, 2022, v. 41, n. 4, p. 719, doi. 10.1002/sim.9253
- By:
- Publication type:
- Article
Doubly robust estimation of the weighted average treatment effect for a target population.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Estimating individualized optimal combination therapies through outcome weighted deep learning algorithms.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Quantifying the totality of treatment effect with multiple event-time observations in the presence of a terminal event from a comparative clinical study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comment on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62:2595-2604.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Heterogeneous individual risk modelling of recurrent events.
- Published in:
- Biometrika, 2021, v. 108, n. 1, p. 183, doi. 10.1093/biomet/asaa053
- By:
- Publication type:
- Article
Optimal individualized treatment rule for combination treatments under budget constraints.
- Published in:
- Journal of the Royal Statistical Society: Series B (Statistical Methodology), 2024, v. 86, n. 3, p. 714, doi. 10.1093/jrsssb/qkad141
- By:
- Publication type:
- Article
Erratum to: Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis.
- Published in:
- Diabetes Therapy, 2015, v. 6, n. 4, p. 651, doi. 10.1007/s13300-015-0132-0
- By:
- Publication type:
- Article
Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis.
- Published in:
- Diabetes Therapy, 2015, v. 6, n. 3, p. 317, doi. 10.1007/s13300-015-0119-x
- By:
- Publication type:
- Article
Stabilized direct learning for efficient estimation of individualized treatment rules.
- Published in:
- Biometrics, 2023, v. 79, n. 4, p. 2843, doi. 10.1111/biom.13818
- By:
- Publication type:
- Article
Net benefit index: Assessing the influence of a biomarker for individualized treatment rules.
- Published in:
- Biometrics, 2021, v. 77, n. 4, p. 1254, doi. 10.1111/biom.13373
- By:
- Publication type:
- Article
On using electronic health records to improve optimal treatment rules in randomized trials.
- Published in:
- Biometrics, 2020, v. 76, n. 4, p. 1075, doi. 10.1111/biom.13288
- By:
- Publication type:
- Article
Estimating individualized treatment rules for ordinal treatments.
- Published in:
- Biometrics, 2018, v. 74, n. 3, p. 924, doi. 10.1111/biom.12865
- By:
- Publication type:
- Article
Efficiency of two sample tests via the restricted mean survival time for analyzing event time observations.
- Published in:
- Biometrics, 2018, v. 74, n. 2, p. 694, doi. 10.1111/biom.12770
- By:
- Publication type:
- Article
Simultaneous variable selection for joint models of longitudinal and survival outcomes.
- Published in:
- Biometrics, 2015, v. 71, n. 1, p. 178, doi. 10.1111/biom.12221
- By:
- Publication type:
- Article
Near-optimal Individualized Treatment Recommendations.
- Published in:
- Journal of Machine Learning Research, 2020, v. 21, n. 146-188, p. 1
- By:
- Publication type:
- Article
Identification of subgroups with differential treatment effects for longitudinal and multiresponse variables.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Estimating optimal treatment regimes via subgroup identification in randomized control trials and observational studies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Incorporation of individual-patient data in network meta-analysis for multiple continuous endpoints, with application to diabetes treatment.
- Published in:
- Statistics in Medicine, 2015, v. 34, n. 20, p. 2794, doi. 10.1002/sim.6519
- By:
- Publication type:
- Article
Detecting outlying trials in network meta-analysis.
- Published in:
- Statistics in Medicine, 2015, v. 34, n. 19, p. 2695, doi. 10.1002/sim.6509
- By:
- Publication type:
- Article
Estimate variable importance for recurrent event outcomes with an application to identify hypoglycemia risk factors.
- Published in:
- Statistics in Medicine, 2015, v. 34, n. 19, p. 2743, doi. 10.1002/sim.6516
- By:
- Publication type:
- Article
Bayesian indirect and mixed treatment comparisons across longitudinal time points.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 15, p. 2613, doi. 10.1002/sim.5688
- By:
- Publication type:
- Article
Joint modeling of progression-free survival and overall survival by a Bayesian normal induced copula estimation model.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 2, p. 240, doi. 10.1002/sim.5487
- By:
- Publication type:
- Article
Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies.
- Published in:
- Annals of Internal Medicine, 2015, v. 163, n. 2, p. 127, doi. 10.7326/M14-1741
- By:
- Publication type:
- Article
Crossover design and its application in late-phase diabetes studies.
- Published in:
- Journal of Diabetes, 2016, v. 8, n. 5, p. 610, doi. 10.1111/1753-0407.12412
- By:
- Publication type:
- Article
Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Response to Comment on Kazda et al. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249.
- Published in:
- 2016
- By:
- Publication type:
- letter
Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies.
- Published in:
- Diabetes Care, 2016, v. 39, n. 11, p. e199, doi. 10.2337/dci16-0030
- By:
- Publication type:
- Article
Perspectives on Some Controversies in Cardiovascular Disease Risk Assessment in the Pharmaceutical Development of Glucose-Lowering Medications.
- Published in:
- 2016
- By:
- Publication type:
- journal article